Cardiac rehabilitation for patients with heart failure: association with readmission and mortality risk.


Journal

European heart journal. Quality of care & clinical outcomes
ISSN: 2058-1742
Titre abrégé: Eur Heart J Qual Care Clin Outcomes
Pays: England
ID NLM: 101677796

Informations de publication

Date de publication:
17 11 2022
Historique:
received: 16 09 2021
revised: 08 11 2021
accepted: 17 11 2021
pubmed: 2 12 2021
medline: 22 11 2022
entrez: 1 12 2021
Statut: ppublish

Résumé

To examine the temporal trends and factors associated with national cardiac rehabilitation (CR) referral and compare the risk of hospital readmission and mortality in those referred for CR versus no referral. This cohort study includes all adult patients alive 120 days from incident heart failure (HF) identified by the Danish Heart Failure Registry (n = 33 257) between 2010 and 2018. Multivariable logistic regression models were used to assess the association between CR referral and patient factors and acute all-cause hospital readmission and mortality at 1 year following HF admission. Overall, 46.7% of HF patients were referred to CR, increasing from 31.7% in 2010 to 52.2% in 2018. Several factors were associated with lower odds of CR referral: male sex [odds ratio (OR): 0.85; 95% confidence interval: 0.80-0.89], older age, unemployment, retirement, living alone, non-Danish ethnic origin, low educational level, New York Heart Association (NYHA) class IV vs. I (OR: 0.75; 0.60-0.95), left ventricular ejection fraction >40%, and comorbidity (stroke, chronic kidney disease, atrial fibrillation/flutter, and diabetes). Myocardial infarction, arthritis, coronary artery bypass grafting, percutaneous coronary intervention, valvular surgery, NYHA class II, and use of angiotensin-converting enzyme inhibitors were associated with higher odds of CR referral. CR referral was associated with lower risk of acute all-cause readmission (OR: 0.92; 0.87-0.97) and all-cause mortality (OR: 0.65; 0.58-0.72). Although increased over time, only one in two HF patients in Denmark were referred to CR in 2018. Strategies are needed to reduce referral disparities, focusing on subgroups of patients at highest risk of non-referral.

Identifiants

pubmed: 34850879
pii: 6446806
doi: 10.1093/ehjqcco/qcab086
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

830-839

Commentaires et corrections

Type : CommentIn

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology.

Auteurs

Lau Caspar Thygesen (LC)

National Institute of Public Health, University of Southern Denmark, Studiestræde 6, DK-1455 Copenhagen, Denmark.

Line Zinckernagel (L)

National Institute of Public Health, University of Southern Denmark, Studiestræde 6, DK-1455 Copenhagen, Denmark.

Hasnain Dalal (H)

University of Exeter Medical School, Knowledge Spa, Royal Cornwall Hospital, Truro, UK.
Primary Care Research Group, University of Exeter Medical School, St Luke's Campus, Exeter, UK.

Kenneth Egstrup (K)

Department of Cardiovascular Research, Odense University Hospital, Svendborg, Denmark.

Charlotte Glümer (C)

Center for Diabetes in the City of Copenhagen, Copenhagen, Denmark.

Morten Grønbæk (M)

National Institute of Public Health, University of Southern Denmark, Studiestræde 6, DK-1455 Copenhagen, Denmark.

Teresa Holmberg (T)

National Institute of Public Health, University of Southern Denmark, Studiestræde 6, DK-1455 Copenhagen, Denmark.

Lars Køber (L)

Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.

Karen la Cour (K)

Department of Public Health, University of Southern Denmark, Odense, Denmark.

Anne Nakano (A)

The Danish Clinical Registries (RKKP), Aarhus. Denmark.

Claus Vinther Nielsen (CV)

Institute of Public Health, Aarhus University, Aarhus, Denmark.
DEFACTUM, Central Denmark Region, Aarhus, Denmark.
Regional Hospital West Jutland, Herning, Denmark.

Kirstine Lærum Sibilitz (KL)

Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.

Janne Schurmann Tolstrup (JS)

National Institute of Public Health, University of Southern Denmark, Studiestræde 6, DK-1455 Copenhagen, Denmark.

Ann Dorthe Zwisler (AD)

REHPA, The Danish Knowledge Centre for Rehabilitation and Palliative Care, Odense University Hospital and University of Southern Denmark, Nyborg, Denmark.

Rod S Taylor (RS)

National Institute of Public Health, University of Southern Denmark, Studiestræde 6, DK-1455 Copenhagen, Denmark.
Institute of Health and Well Being, University of Glasgow, Glasgow, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH